Supplementation with n-3 polyunsaturated fatty acids to lipopolysaccharide-induced rats improved inflammation and functional properties of renal Na,K-ATPase

Nutr Res. 2013 Sep;33(9):772-9. doi: 10.1016/j.nutres.2013.06.001. Epub 2013 Jul 26.

Abstract

Measurements of enzyme kinetics of renal Na, K-ATPase were used for characterization of ATP- and Na⁺-binding sites in rats that were subjected to 10 days of moderate inflammation that was induced by a single dose of Escherichia coli lipopolysaccharides (LPSs) at a dose of 1 mg kg⁻¹ body weight. We hypothesized that LPSs might initiate a malfunction of renal Na, K-ATPase, which is a key enzyme involved in regulation of sodium homeostasis in the organism. We also investigated the potential effect that fish oil (FO) has in the prevention of Na, K-ATPase alterations by administering FO daily at a dose of 30 mg kg⁻¹. Alone, LPS elevated the level of C-reactive protein by more than 500% and free radicals by 36% in plasma, as indicated by an increased level of malondialdehyde. The Na, K-ATPase was slightly altered in the vicinity of the ATP-binding site as suggested by the 9% increase of the concentration of ATP necessary for half-maximal activation of the enzyme, thus indicating a deteriorated binding of ATP as a consequence of inflammation. Daily supplementation of FO partly attenuated LPS-induced injury, as observed by a significant decrease in the plasma levels of C-reactive protein and free radicals, hence maintaining the activity of renal Na, K-ATPase to the level of healthy control animals. In conclusion, our findings showed that FO prevented an excessive malondialdehyde production in LPS-treated animals and stabilized renal Na, K-ATPase.

Keywords: C; DHAs; FO; Fish oil; HR; Inflammation; K(m); Kidney; LPS; MDA; NaCl; ROS; Rat; SBP; Sodium pump; V(max); concentration of ATP necessary for half-maximal activation of the enzyme; control group; docosahexaenoic acid; fish oil; heart rate; lipopolysaccharides; malondialdehyde; maximum velocity; n-3 PUFA; polyunsaturated fatty acid; reactive oxygen species; sodium chloride; systolic blood pressure.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood Pressure / drug effects
  • Body Weight / drug effects
  • C-Reactive Protein / metabolism
  • Dietary Supplements*
  • Fatty Acids, Omega-3 / administration & dosage*
  • Fish Oils / administration & dosage
  • Heart Rate / drug effects
  • Inflammation / drug therapy
  • Kidney / drug effects*
  • Kidney / enzymology
  • Lipopolysaccharides / adverse effects*
  • Male
  • Malondialdehyde / blood
  • Organ Size / drug effects
  • Rats
  • Rats, Wistar
  • Sodium / metabolism
  • Sodium-Potassium-Exchanging ATPase / metabolism*

Substances

  • Fatty Acids, Omega-3
  • Fish Oils
  • Lipopolysaccharides
  • Malondialdehyde
  • C-Reactive Protein
  • Sodium
  • Sodium-Potassium-Exchanging ATPase